Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages - Impact of phagocytosis on viability and cytokine production

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 7, 2004, Pages 883-891

  Olbrich, Carsten ^a,b   Schöler, Nadja ^a   Tabatt, Kerstin ^a   Kayser, Oliver ^a   Müller, Rainer Helmut ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CETYLPYRIDINIUM SALT; CHOLIC ACID; CYTOCHALASIN B; CYTOKINE; DODECYL SULFATE SODIUM; DYNASAN 114; INTERLEUKIN 12; INTERLEUKIN 6; LIPID; POLOXAMER; POLOXAMINE 908; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; STABILIZING AGENT; SURFACTANT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL LINE; CELL STIMULATION; CELL VIABILITY; COLLOID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EXPERIMENTAL ANIMAL; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM CELL; PHAGOCYTOSIS; SYNTHESIS; TOXICITY TESTING;

ANIMALS; CELL LINE; CELL SURVIVAL; CYTOKINES; LIPOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NANOTECHNOLOGY; PHAGOCYTOSIS; SURFACE-ACTIVE AGENTS; TOXICITY TESTS; TRIGLYCERIDES;

EID: 3042735591     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023754     Document Type: Article

References (49)

1. Baumann, H., Gauldie, J. (1994) The acute phase response. Immunol. Today 15: 74-80
2. Catelas, I., Huk, O. L., Petit, A., Zukor, D. J., Marchand, R., Yahia, L. (1998) Flow cytometric analysis of macrophage response to ceramic and polyethylene particles: effect of size, concentration and composition. J. Biomed. Mater. Res. 41: 600-607
3. Claudio, E., Segade, F., Wrobel, K., Ramos, S., Lazo, P. S. (1995) Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death. Am. J. Resp. Cell. Mol. Biol. 13: 547-554
4. Cruz, T., Rogerio, G., Donato, A., Lopes, C. (1997) Interaction between polycyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism. NBT reduction and NO production. Pharm. Res. 14: 73-79
5. Fraley, R., Straubinger. R. M., Rule, G., Springer, E. L., Papahadjopoulos. D. (1981) Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry 20: 6978-6987
6. Gessner, A., Olbrich, C., Kayser, O., Müller, R. H. (2001) Serum protein adsorption on lipid drug conjugate nanoparticles: a comparison of species dependant adsorption patterns. Int. J. Pharm. 214: 87-91
7. Green, T. R., Fisher, J., Stone, M., Wroblewsky, B. M., Ingham, E. (1998) Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19: 2297-2302
8. Harding, C. V., Leyva-Cobian, F., Unanue, E. R. (1988) Mechanism of antigen processing. Immunol. Rev. 106: 77-92
9. Illum, L., Hunneyball, I. M., Davies, S. S. (1986) The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int. J. Pharm. 29: 53-65
10. Illum, L., Davis, S. S., Müller, R. H., Mak, E., West, P. (1987) The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer - poloxamine 908. Life Sci. 40: 367-374
11. Kawai, Y., Takasuka, N., Inoue, K., Akagawa, K., Nishijima, A. (2000) Ornithine-containing lipids stimulate CD 14-dependent TNF-α production from murine macrophage-like J774.1 and RAW 264.7 cells. FEMS Immunol. Med. Microbiol. 28: 197-203
12. Kubo, A., Minamino, N., Isumi, Y., Katafuchi, T., Kangawa, K., Dohi, K., Matsuo, H. (1998) Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 273: 16 730-16 738
13. Lherm, C., Mueller, R. H., Puisieux, P., Couvreur, P. (1991) Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain lengths. Int. J. Pharm. 84: 13-22
14. Martin, A., Audran, R., Collet, B., Lancien, G., Toujas, L. (1992) Monoclonal antibody AMH152 reacts with human monocytes in culture and with inflammatory macrophages. Res. Immunol. 143: 39-47
15. Mehnert, W., zur Mühlen, A., Dingler, A., Weyhers, H., Müller, R.H. (1997) Solid lipid nanoparticles - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. 2. Mitteilung: Wirkstoff-Inkorporation. Freisetzung und Sterilisierbarkeit. Pharm. Ind. 59: 511-514
16. Mosmann, T. R. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65: 55-63
17. Müller, R. H. (1991) Colloidal carriers for controlled drug delivery and targeting - modification. Characterization and in vivo distribution. Wissenschaftliche Verlagsgesellschaft Stuttgart, CRC Press Boca Raton, pp 379
18. Müller, R. H., Lucks, J. S. (1996) Arzneistoffträger aus festen Lipidteilchen. Feste Lipidnanosphären (SLN), Eur. Pat. 0605497
19. Müller, R. H., Olbrich, C. (1999a) Solid Lipid Nanoparticles (SLN): phagocytic uptake, in vitro cytotoxity and in vivo biodegradation. 1st Communication. Pharm. Ind. 61: 462-467
20. Müller, R. H., Olbrich, C. (1999b) Solid Lipid Nanoparticles (SLN): Phagocytic uptake. in vitro cytotoxity and in vivo biodegradation. 2nd Communication. Pharm. Ind. 61: 564-569
21. Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., zur Mühlen, A., Weyhers, H., Freitas, C., Rühl, D. (1995) Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. 41: 62-69
22. Müller R. H., Maassen, S., Weyhers, H., Mehnert, W. (1996) Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target. 4: 161-170
23. Müller, R. H., Maaßen, S., Schwarz, C., Mehnert, W. (1997a) Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J. Control. Release 47: 261-269
24. Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., Mehnert, W. (1997b) Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res. 14: 458-462
25. Müller, R. H., Grubhofer, N., Olbrich, C. (1999) Stabilitäts-, Biokompatibilitäts-optimiertes Adjuvans (SBA) zur Erhöhung der humoralen und zellulären Immunantwort. German Patent Application No. 199 23 256.3
26. Müller, R. H., Mäder, K., Gohla, S. (2000a) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50: 161-177
27. Müller, R. H., Dingler, A., Schneppe, T., Gohla, S. (2000b) Large scale production of solid lipid nanoparticles (SLN) and nanosuspensions (DissoCubesTM). In: Wise, D. (ed.) Handbook of pharmaceutical controlled release technology. Dekker, New York, Basle, pp 359-376
28. Olbrich, C., Kayser, O., Müller, R. H., Grubhofer, N. (2000) Solid lipid nanoparticles (SLN) as vaccine adjuvant - study in sheep with a mycoplasma bovis antigen and stability testing. Intern. Symp. Control. Rel. Bioact. Mater. 27: 568-569
29. Olbrich, C., Gessner, A., Schröder, W., Kiderlen, A. F., Kayser, O., Müller, R. H. (2004) Lipid-drug conjugate (LDC) nanoparticles of the hydrophilic drug diminazene - cytotoxicity testing and mouse serum adsorption. J. Control. Release 96: 425-435
30. Ott, G. L., Barchfeld, D., Chernoff, R., Radhakrishnan, P., van Hoogevest, H., Van Nest, G. (1995) MF59, Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm. Biotechnol. 6: 277-296
31. Park, S. Y., Ji, G. E., Ko, Y. T., Jung, H. K., Ustunol, Z., Pestka, J. J. (1999) Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241
32. Peracchia, M. T., Vauthier, C., Desmaele, D., Gulik, A., Dedieu, J. C., Demoy, M., d'Angelo, J., Couvreur, P. (1998) Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecylcyanoacrylate amphiphilic copolymer. Pharm Res.15: 550-556
33. Ralph, P., Nakoinz, I. (1977) Antibody-dependant killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPSJ. Immunology 119: 950-954
34. Raschke, W. C., Baird, S., Ralph, P., Nakoinz, I. (1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15: 261-267
35. Rudt, S., Müller, R. H. (1992) In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters. particle size and particle concentration. J. Control. Release 22: 263-272
36. Schöler, N., Zimmermann, E., Müller, R. H., Hahn, H., Liesenfeld, O. (1999) Interaktion von Solid Lipid Nanoparticles (SLN), neuartigen Wirkstoff-Carriern, mit mononukleären Zellen. 51. Annual Meeting of the "Deutsche Gesellschaft für Hygiene und Mikrobiologie
37. Schöler, N., Zimmermann, E., Katzfey, U., Hahn, H., Müller, R. H., Liesenfeld, O. (2000a) Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages. J. Microencapsulation 17: 639-650
38. Schöler, N., Zimmermann, E., Katzfey, U., Hahn, H., Müller, R.H., Liesenfeld, O. (2000b) Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. Int. J. Pharm. 23: 235-239
39. Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H., Liesenfeld, O. (2000c) Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int. J. Pharm. 221: 57-67
40. Schmolka, I. R. (1977) A review of block polymer surfactants. J. Am. Chem. Soc. 54: 110-116
41. Schwarz, C., Mehnert, W., Lucks, J. S., Müller, R. H. (1993) Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production. characterisation and sterilisation. J. Control. Release 30: 83-96
42. Soma, C. E., Dubernet, C., Barratt, G., Benita, S., Couvreur, P. (2000) Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro. J. Control. Release 68: 283-289
43. Van Furth, R., Cohn, Z. A., Hirsch, J. G., Spector, W. G., Langevoort, H. L. (1972) The mononuclear phagocyte system. A new classification of macrophages and their precursor cells. Bull. WHO. 46: 845
44. Van Oss, C. J., Gillmann, C. F., Neumann, A. W. (1975) Phagocytic engulfment and cell adhesivness as cellular surface phenomena. Marcel Dekker, New York
45. Van Oss, C. J., Absolom, D. R., Neumann, A. W. (1983) Interaction of phagocytes with other blood cells and with pathogenic and nonpathogenic microbes. Ann. N. Y. Acad. Sci. 416: 332-350
46. Wattiaux, R., Jadot, M., Warnier-Pirotte, M.-T., Wattiaux-De Coninck, I. (1997) Cationic lipids destabilize lysosomal membrane in vitro. FEBS Lett. 417: 199-201
47. Yang, S. C., Lu, L. F., Ying, C., Zhu, J. B., Bing, W. L., Yang, Z. Z. (1999) Body distribution in mice of intravenously injected campothecin solid lipid nanoparticles and drug targeting effect on brain. J. Control. Release 59: 299-307
48. Zur Mühlen, A., Schwarz, C., Mehnert, W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery. drug release and release mechanism. Eur. J. Pharm. Biopharm. 45: 149-155
49. Zhou, X., Leaf, H. (1994) DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta 1189: 195-203